{"transactions":[{"id":705132,"issuer":{"id":8413,"kind":"organization","name":"ARTELO BIOSCIENCES, INC."},"owners":[{"id":29281,"kind":"person","name":"MATSUI CONNIE","position":1,"cik":"0001236537","reported_name":"MATSUI CONNIE","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2026-07-21T22:31:46.000Z","date":"2026-07-17","kind":"grant","planned":false,"acquired":true,"shares":136,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Subject to the Reporting Person continuing to be a Service Provider (as such term is defined in the Issuer's Plan) through each such applicable vesting date, one hundred percent (100%) of the shares subject to the option shall vest on the earlier of (i) the one (1) year anniversary of the Vesting Commencement Date, or (ii) the day prior to the date of the annual meeting of the Issuer's stockholders next following the Vesting Commencement Date. \"Vesting Commencement Date\" shall mean July 17, 2026."}],"balance_after":136,"derivative":{"exercise_price":1.15,"expiration_date":"2036-07-17","underlying":"Common Stock","underlying_shares":136},"source":{"system":"sec-edgar","filing":"0001640334-26-001231","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1236537/000164033426001231/form4.xml","form_type":"4"}},{"id":744390,"issuer":{"id":5797,"kind":"organization","name":"SUTRO BIOPHARMA, INC.","symbol":"STRO"},"owners":[{"id":29281,"kind":"person","name":"MATSUI CONNIE","position":1,"cik":"0001236537","reported_name":"MATSUI CONNIE","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2026-06-09T20:12:59.000Z","date":"2026-06-05","kind":"grant","planned":false,"acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option shall vest, subject to the reporting person's provision of service to the issuer on each vesting date, as to 8.33% of the total award monthly, with the first tranche vesting on July 5, 2026, and the award shall be fully vested and exercisable on the earlier of (i) the date of the issuer's 2027 annual stockholders meeting or (ii) June 5, 2027."}],"balance_after":10000,"derivative":{"exercise_price":26.09,"expiration_date":"2036-06-05","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001236537-26-000002","document":"form4-06092026_080655.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1236537/000123653726000002/form4-06092026_080655.xml","form_type":"4"}},{"id":924726,"issuer":{"id":8413,"kind":"organization","name":"ARTELO BIOSCIENCES, INC."},"owners":[{"id":29281,"kind":"person","name":"MATSUI CONNIE","position":1,"cik":"0001236537","reported_name":"MATSUI CONNIE","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options (right to buy)","published_at":"2026-02-02T21:57:43.000Z","date":"2026-01-30","kind":"grant","planned":false,"acquired":true,"shares":292,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Subject to the Reporting Person continuing to be a Service Provider (as such term is defined in the Issuer's Plan) through each such applicable vesting date, one hundred percent (100%) of the shares subject to the option shall vest on the earlier of (i) the one (1) year anniversary of the Vesting Commencement Date, or (ii) the day prior to the date of the annual meeting of the Issuer's stockholders next following the Vesting Commencement Date. \"Vesting Commencement Date\" shall mean January 30, 2026."}],"balance_after":292,"derivative":{"exercise_price":1.71,"expiration_date":"2036-01-30","underlying":"Common Stock","underlying_shares":292},"source":{"system":"sec-edgar","filing":"0001640334-26-000199","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1236537/000164033426000199/form4.xml","form_type":"4"}},{"id":958056,"issuer":{"id":5797,"kind":"organization","name":"SUTRO BIOPHARMA, INC.","symbol":"STRO"},"owners":[{"id":29281,"kind":"person","name":"MATSUI CONNIE","position":1,"cik":"0001236537","reported_name":"MATSUI CONNIE","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2025-12-29T22:03:16.000Z","date":"2025-12-23","kind":"grant","planned":false,"acquired":true,"shares":1500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option shall vest as to 16.67% of the total award monthly, subject to the reporting person's continued service to the issuer on each vesting date, with the first tranche vesting on January 23, 2026."}],"balance_after":1500,"derivative":{"exercise_price":10.38,"expiration_date":"2035-12-23","underlying":"Common Stock","underlying_shares":1500},"source":{"system":"sec-edgar","filing":"0001236537-25-000008","document":"form4-12292025_101213.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1236537/000123653725000008/form4-12292025_101213.xml","form_type":"4"}},{"id":1011250,"issuer":{"id":8413,"kind":"organization","name":"ARTELO BIOSCIENCES, INC."},"owners":[{"id":29281,"kind":"person","name":"MATSUI CONNIE","position":1,"cik":"0001236537","reported_name":"MATSUI CONNIE","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Convertible Promissory Note","published_at":"2025-10-31T01:30:05.000Z","date":"2025-10-28","kind":"exercise","planned":false,"acquired":true,"price":110843,"reported_value":110843,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Pursuant to the terms of the convertible note issued to the Reporting Person on May 1, 2025 (the \"May Note\"), on October 28, 2025, a portion of the May Note was automatically converted into a warrant to purchase shares of the Issuer's common stock (\"Common Stock\") (the \"$6.24 Warrant\")."},{"field":"kind","element":"transactionCoding","label":"F2","text":"On October 28, 2025, the Issuer entered into a Subscription Agreement (the \"Subscription Agreement\") pursuant to which certain investors, including the Reporting Person, converted and reinvested the portion of the May Note not converted into the $6.24 Warrant into (i) a convertible note (the \"October Note\"), and (ii) a warrant to purchase shares of the Issuer's Common Stock pursuant to the Subscription Agreement (the \"$3.40 Warrant\"). At any time prior to payment in full of the principal amount of the October Note, the Reporting Person has the right to convert the principal amount of the October Note, together with the accrued and unpaid interest thereon, into shares of the Issuer's Common Stock."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F1","text":"Pursuant to the terms of the convertible note issued to the Reporting Person on May 1, 2025 (the \"May Note\"), on October 28, 2025, a portion of the May Note was automatically converted into a warrant to purchase shares of the Issuer's common stock (\"Common Stock\") (the \"$6.24 Warrant\")."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F2","text":"On October 28, 2025, the Issuer entered into a Subscription Agreement (the \"Subscription Agreement\") pursuant to which certain investors, including the Reporting Person, converted and reinvested the portion of the May Note not converted into the $6.24 Warrant into (i) a convertible note (the \"October Note\"), and (ii) a warrant to purchase shares of the Issuer's Common Stock pursuant to the Subscription Agreement (the \"$3.40 Warrant\"). At any time prior to payment in full of the principal amount of the October Note, the Reporting Person has the right to convert the principal amount of the October Note, together with the accrued and unpaid interest thereon, into shares of the Issuer's Common Stock."}],"derivative":{"exercise_price":3.4,"exercise_date":"2025-10-28","expiration_date":"2026-04-28","underlying":"Common Stock"},"source":{"system":"sec-edgar","filing":"0001640334-25-001925","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1236537/000164033425001925/form4.xml","form_type":"4"}},{"id":1011249,"issuer":{"id":8413,"kind":"organization","name":"ARTELO BIOSCIENCES, INC."},"owners":[{"id":29281,"kind":"person","name":"MATSUI CONNIE","position":1,"cik":"0001236537","reported_name":"MATSUI CONNIE","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Warrant (right to buy)","published_at":"2025-10-31T01:30:05.000Z","date":"2025-10-28","kind":"exercise","planned":false,"acquired":true,"shares":70376,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"On October 28, 2025, the Issuer entered into a Subscription Agreement (the \"Subscription Agreement\") pursuant to which certain investors, including the Reporting Person, converted and reinvested the portion of the May Note not converted into the $6.24 Warrant into (i) a convertible note (the \"October Note\"), and (ii) a warrant to purchase shares of the Issuer's Common Stock pursuant to the Subscription Agreement (the \"$3.40 Warrant\"). At any time prior to payment in full of the principal amount of the October Note, the Reporting Person has the right to convert the principal amount of the October Note, together with the accrued and unpaid interest thereon, into shares of the Issuer's Common Stock."},{"field":"kind","element":"transactionCoding","label":"F1","text":"Pursuant to the terms of the convertible note issued to the Reporting Person on May 1, 2025 (the \"May Note\"), on October 28, 2025, a portion of the May Note was automatically converted into a warrant to purchase shares of the Issuer's common stock (\"Common Stock\") (the \"$6.24 Warrant\")."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"On October 28, 2025, the Issuer entered into a Subscription Agreement (the \"Subscription Agreement\") pursuant to which certain investors, including the Reporting Person, converted and reinvested the portion of the May Note not converted into the $6.24 Warrant into (i) a convertible note (the \"October Note\"), and (ii) a warrant to purchase shares of the Issuer's Common Stock pursuant to the Subscription Agreement (the \"$3.40 Warrant\"). At any time prior to payment in full of the principal amount of the October Note, the Reporting Person has the right to convert the principal amount of the October Note, together with the accrued and unpaid interest thereon, into shares of the Issuer's Common Stock."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Pursuant to the terms of the convertible note issued to the Reporting Person on May 1, 2025 (the \"May Note\"), on October 28, 2025, a portion of the May Note was automatically converted into a warrant to purchase shares of the Issuer's common stock (\"Common Stock\") (the \"$6.24 Warrant\")."}],"balance_after":70376,"derivative":{"exercise_price":3.4,"exercise_date":"2025-10-28","expiration_date":"2030-10-28","underlying":"Common Stock","underlying_shares":70376},"source":{"system":"sec-edgar","filing":"0001640334-25-001925","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1236537/000164033425001925/form4.xml","form_type":"4"}},{"id":1011248,"issuer":{"id":8413,"kind":"organization","name":"ARTELO BIOSCIENCES, INC."},"owners":[{"id":29281,"kind":"person","name":"MATSUI CONNIE","position":1,"cik":"0001236537","reported_name":"MATSUI CONNIE","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Warrant (right to buy)","published_at":"2025-10-31T01:30:05.000Z","date":"2025-10-28","kind":"exercise","planned":false,"acquired":true,"shares":38346,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"On October 28, 2025, the Issuer entered into a Subscription Agreement (the \"Subscription Agreement\") pursuant to which certain investors, including the Reporting Person, converted and reinvested the portion of the May Note not converted into the $6.24 Warrant into (i) a convertible note (the \"October Note\"), and (ii) a warrant to purchase shares of the Issuer's Common Stock pursuant to the Subscription Agreement (the \"$3.40 Warrant\"). At any time prior to payment in full of the principal amount of the October Note, the Reporting Person has the right to convert the principal amount of the October Note, together with the accrued and unpaid interest thereon, into shares of the Issuer's Common Stock."},{"field":"kind","element":"transactionCoding","label":"F1","text":"Pursuant to the terms of the convertible note issued to the Reporting Person on May 1, 2025 (the \"May Note\"), on October 28, 2025, a portion of the May Note was automatically converted into a warrant to purchase shares of the Issuer's common stock (\"Common Stock\") (the \"$6.24 Warrant\")."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Pursuant to the terms of the convertible note issued to the Reporting Person on May 1, 2025 (the \"May Note\"), on October 28, 2025, a portion of the May Note was automatically converted into a warrant to purchase shares of the Issuer's common stock (\"Common Stock\") (the \"$6.24 Warrant\")."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"On October 28, 2025, the Issuer entered into a Subscription Agreement (the \"Subscription Agreement\") pursuant to which certain investors, including the Reporting Person, converted and reinvested the portion of the May Note not converted into the $6.24 Warrant into (i) a convertible note (the \"October Note\"), and (ii) a warrant to purchase shares of the Issuer's Common Stock pursuant to the Subscription Agreement (the \"$3.40 Warrant\"). At any time prior to payment in full of the principal amount of the October Note, the Reporting Person has the right to convert the principal amount of the October Note, together with the accrued and unpaid interest thereon, into shares of the Issuer's Common Stock."}],"balance_after":38346,"derivative":{"exercise_price":6.24,"exercise_date":"2025-10-28","expiration_date":"2030-10-28","underlying":"Common Stock","underlying_shares":38346},"source":{"system":"sec-edgar","filing":"0001640334-25-001925","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1236537/000164033425001925/form4.xml","form_type":"4"}},{"id":1011247,"issuer":{"id":8413,"kind":"organization","name":"ARTELO BIOSCIENCES, INC."},"owners":[{"id":29281,"kind":"person","name":"MATSUI CONNIE","position":1,"cik":"0001236537","reported_name":"MATSUI CONNIE","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Convertible Promissory Note","published_at":"2025-10-31T01:30:05.000Z","date":"2025-10-28","kind":"exercise","planned":false,"acquired":false,"price":140000,"reported_value":140000,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Pursuant to the terms of the convertible note issued to the Reporting Person on May 1, 2025 (the \"May Note\"), on October 28, 2025, a portion of the May Note was automatically converted into a warrant to purchase shares of the Issuer's common stock (\"Common Stock\") (the \"$6.24 Warrant\")."},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"On October 28, 2025, the Issuer entered into a Subscription Agreement (the \"Subscription Agreement\") pursuant to which certain investors, including the Reporting Person, converted and reinvested the portion of the May Note not converted into the $6.24 Warrant into (i) a convertible note (the \"October Note\"), and (ii) a warrant to purchase shares of the Issuer's Common Stock pursuant to the Subscription Agreement (the \"$3.40 Warrant\"). At any time prior to payment in full of the principal amount of the October Note, the Reporting Person has the right to convert the principal amount of the October Note, together with the accrued and unpaid interest thereon, into shares of the Issuer's Common Stock."},{"field":"kind","element":"transactionCoding","label":"F2","text":"On October 28, 2025, the Issuer entered into a Subscription Agreement (the \"Subscription Agreement\") pursuant to which certain investors, including the Reporting Person, converted and reinvested the portion of the May Note not converted into the $6.24 Warrant into (i) a convertible note (the \"October Note\"), and (ii) a warrant to purchase shares of the Issuer's Common Stock pursuant to the Subscription Agreement (the \"$3.40 Warrant\"). At any time prior to payment in full of the principal amount of the October Note, the Reporting Person has the right to convert the principal amount of the October Note, together with the accrued and unpaid interest thereon, into shares of the Issuer's Common Stock."},{"field":"kind","element":"transactionCoding","label":"F1","text":"Pursuant to the terms of the convertible note issued to the Reporting Person on May 1, 2025 (the \"May Note\"), on October 28, 2025, a portion of the May Note was automatically converted into a warrant to purchase shares of the Issuer's common stock (\"Common Stock\") (the \"$6.24 Warrant\")."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F2","text":"On October 28, 2025, the Issuer entered into a Subscription Agreement (the \"Subscription Agreement\") pursuant to which certain investors, including the Reporting Person, converted and reinvested the portion of the May Note not converted into the $6.24 Warrant into (i) a convertible note (the \"October Note\"), and (ii) a warrant to purchase shares of the Issuer's Common Stock pursuant to the Subscription Agreement (the \"$3.40 Warrant\"). At any time prior to payment in full of the principal amount of the October Note, the Reporting Person has the right to convert the principal amount of the October Note, together with the accrued and unpaid interest thereon, into shares of the Issuer's Common Stock."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F1","text":"Pursuant to the terms of the convertible note issued to the Reporting Person on May 1, 2025 (the \"May Note\"), on October 28, 2025, a portion of the May Note was automatically converted into a warrant to purchase shares of the Issuer's common stock (\"Common Stock\") (the \"$6.24 Warrant\")."}],"derivative":{"exercise_date":"2025-05-01","expiration_date":"2025-10-28","underlying":"Common Stock"},"source":{"system":"sec-edgar","filing":"0001640334-25-001925","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1236537/000164033425001925/form4.xml","form_type":"4"}},{"id":1017494,"issuer":{"id":5797,"kind":"organization","name":"SUTRO BIOPHARMA, INC.","symbol":"STRO"},"owners":[{"id":29281,"kind":"person","name":"MATSUI CONNIE","position":1,"cik":"0001236537","reported_name":"MATSUI CONNIE","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-10-16T12:15:49.000Z","date":"2025-10-15","kind":"purchase","planned":false,"acquired":true,"shares":50000,"price":0.799,"value":39950.0,"ownership":{"direct":true},"balance_after":50000,"source":{"system":"sec-edgar","filing":"0001236537-25-000006","document":"form4-10162025_121046.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1236537/000123653725000006/form4-10162025_121046.xml","form_type":"4"}},{"id":1116158,"issuer":{"id":5797,"kind":"organization","name":"SUTRO BIOPHARMA, INC.","symbol":"STRO"},"owners":[{"id":29281,"kind":"person","name":"MATSUI CONNIE","position":1,"cik":"0001236537","reported_name":"MATSUI CONNIE","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2025-06-10T20:12:06.000Z","date":"2025-06-06","kind":"grant","planned":false,"acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests as to 8.33% of the total shares monthly, commencing July 6, 2025, with 100% of the total shares vested and exercisable on the earlier of the date of the issuer's 2026 annual stockholders meeting or June 6, 2026, subject to the reporting person's provision of service to the issuer on each vesting date."}],"balance_after":50000,"derivative":{"exercise_price":0.85,"expiration_date":"2035-06-06","underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001415889-25-016468","document":"form4-06102025_080602.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1236537/000141588925016468/form4-06102025_080602.xml","form_type":"4"}},{"id":1158891,"issuer":{"id":8413,"kind":"organization","name":"ARTELO BIOSCIENCES, INC."},"owners":[{"id":29281,"kind":"person","name":"MATSUI CONNIE","position":1,"cik":"0001236537","reported_name":"MATSUI CONNIE","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Convertible Promissory Note","published_at":"2025-05-05T21:21:52.000Z","date":"2025-05-01","kind":"purchase","planned":false,"acquired":true,"price":140000,"reported_value":140000,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"On or about May 1, 2025, the Issuer entered into a Subscription Agreement (the \"Subscription Agreement\") with the Reporting Person, pursuant to which the Issuer issued a convertible note (the \"Note\") to the Reporting Person. The Notes will accrue interest at a rate of 12% per annum, which will adjust to 20% upon an Event of Default (as defined in the Note). All unpaid principal, together with any then unpaid and accrued interest and other amounts payable thereunder, shall be due and payable on October 28, 2025 (the \"Maturity Date\")."},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"At the Maturity Date, the Reporting Person may (at the Reporting Person's sole option) convert all of that certain unpaid portion of principal and accrued interest of the Reporting Person's Note into shares of the Issuer's common stock (\"Common Stock\") (the \"Voluntary Conversion\"), specifically into that number of shares of Common Stock (the \"Converted Shares\") equal to the unpaid principal balance and any accrued interest of each Note divided by $1.29. The amount of principal balance and any accrued interest of the Note convertible pursuant to the Voluntary Conversion shall be the number of Converted Shares multiplied by $1.04 (the \"Minimum Price\"). Should the Reporting Person not elect Voluntary Conversion, such portion of the unpaid principal balance and any accrued interest of the Note subject to Voluntary Conversion shall be immediately due and payable in cash."},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"At the Maturity Date, that portion of the unpaid principal balance and any accrued interest of the Note not subject to the Voluntary Conversion shall be automatically converted into a warrant to purchase shares of the Issuer's Common Stock (the \"Warrant\") at a conversion price of $0.125 per share issuable pursuant to the Warrant (the \"Automatic Conversion\"). The exercise price of such Warrant for each Warrant Share shall be equal to the Minimum Price."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F1","text":"On or about May 1, 2025, the Issuer entered into a Subscription Agreement (the \"Subscription Agreement\") with the Reporting Person, pursuant to which the Issuer issued a convertible note (the \"Note\") to the Reporting Person. The Notes will accrue interest at a rate of 12% per annum, which will adjust to 20% upon an Event of Default (as defined in the Note). All unpaid principal, together with any then unpaid and accrued interest and other amounts payable thereunder, shall be due and payable on October 28, 2025 (the \"Maturity Date\")."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F2","text":"At the Maturity Date, the Reporting Person may (at the Reporting Person's sole option) convert all of that certain unpaid portion of principal and accrued interest of the Reporting Person's Note into shares of the Issuer's common stock (\"Common Stock\") (the \"Voluntary Conversion\"), specifically into that number of shares of Common Stock (the \"Converted Shares\") equal to the unpaid principal balance and any accrued interest of each Note divided by $1.29. The amount of principal balance and any accrued interest of the Note convertible pursuant to the Voluntary Conversion shall be the number of Converted Shares multiplied by $1.04 (the \"Minimum Price\"). Should the Reporting Person not elect Voluntary Conversion, such portion of the unpaid principal balance and any accrued interest of the Note subject to Voluntary Conversion shall be immediately due and payable in cash."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F3","text":"At the Maturity Date, that portion of the unpaid principal balance and any accrued interest of the Note not subject to the Voluntary Conversion shall be automatically converted into a warrant to purchase shares of the Issuer's Common Stock (the \"Warrant\") at a conversion price of $0.125 per share issuable pursuant to the Warrant (the \"Automatic Conversion\"). The exercise price of such Warrant for each Warrant Share shall be equal to the Minimum Price."}],"derivative":{"exercise_date":"2025-05-01","expiration_date":"2025-10-28","underlying":"Common Stock"},"source":{"system":"sec-edgar","filing":"0001640334-25-000788","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1236537/000164033425000788/form4.xml","form_type":"4"}},{"id":1322732,"issuer":{"id":8413,"kind":"organization","name":"ARTELO BIOSCIENCES, INC."},"owners":[{"id":29281,"kind":"person","name":"MATSUI CONNIE","position":1,"cik":"0001236537","reported_name":"MATSUI CONNIE","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2024-12-23T21:02:27.000Z","date":"2024-12-20","kind":"grant","planned":false,"acquired":true,"shares":1750,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Subject to the Reporting Person continuing to be a Service Provider (as such term is defined in the Issuer's Plan) through each such applicable vesting date, one hundred percent (100%) of the shares subject to the option shall vest on the earlier of (i) the one (1) year anniversary of the Vesting Commencement Date, or (ii) the day prior to the date of the annual meeting of the Issuer's stockholders next following the Vesting Commencement Date. \"Vesting Commencement Date\" shall mean December 20, 2024."}],"balance_after":1750,"derivative":{"exercise_price":0.9476,"expiration_date":"2034-12-20","underlying":"Common Stock","underlying_shares":1750},"source":{"system":"sec-edgar","filing":"0001640334-24-001935","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1236537/000164033424001935/form4.xml","form_type":"4"}},{"id":1345577,"issuer":{"id":793,"kind":"organization","name":"HALOZYME THERAPEUTICS, INC.","symbol":"HALO"},"owners":[{"id":29281,"kind":"person","name":"MATSUI CONNIE","position":1,"cik":"0001236537","reported_name":"MATSUI CONNIE","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-12-03T21:05:40.000Z","date":"2024-11-29","kind":"gift","planned":false,"acquired":false,"shares":10470,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents a bona fide gift to charity."}],"balance_after":183035,"source":{"system":"sec-edgar","filing":"0001415889-24-028062","document":"form4-12032024_091236.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1159036/000141588924028062/form4-12032024_091236.xml","form_type":"4"}},{"id":1484673,"issuer":{"id":5797,"kind":"organization","name":"SUTRO BIOPHARMA, INC.","symbol":"STRO"},"owners":[{"id":29281,"kind":"person","name":"MATSUI CONNIE","position":1,"cik":"0001236537","reported_name":"MATSUI CONNIE","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2024-06-10T20:26:15.000Z","date":"2024-06-06","kind":"grant","planned":false,"acquired":true,"shares":35000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests as to 8.33% of the total award monthly, commencing July 6, 2024, with 100% of the award vested and exercisable on the earlier of the date of the issuer's 2025 annual stockholders meeting or June 6, 2025, subject to the reporting person's provision of service to the issuer on each vesting date."}],"balance_after":35000,"derivative":{"exercise_price":3.76,"expiration_date":"2034-06-06","underlying":"Common Stock","underlying_shares":35000},"source":{"system":"sec-edgar","filing":"0001415889-24-016219","document":"form4-06102024_080611.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1236537/000141588924016219/form4-06102024_080611.xml","form_type":"4"}},{"id":1533934,"issuer":{"id":793,"kind":"organization","name":"HALOZYME THERAPEUTICS, INC.","symbol":"HALO"},"owners":[{"id":29281,"kind":"person","name":"MATSUI CONNIE","position":1,"cik":"0001236537","reported_name":"MATSUI CONNIE","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option to Purchase Common Stock","published_at":"2024-04-29T22:05:41.000Z","date":"2024-04-25","kind":"grant","planned":false,"acquired":true,"shares":8804,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Represents annual stock option grant under the Issuer's director compensation program.  This grant will vest in full on the earlier of (i) April 25, 2025 and (ii) the date of the Issuer's next annual meeting of stockholders."}],"balance_after":8804,"derivative":{"exercise_price":38.46,"expiration_date":"2034-04-25","underlying":"Common Stock","underlying_shares":8804},"source":{"system":"sec-edgar","filing":"0001415889-24-011698","document":"form4-04292024_100436.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1159036/000141588924011698/form4-04292024_100436.xml","form_type":"4"}},{"id":1533933,"issuer":{"id":793,"kind":"organization","name":"HALOZYME THERAPEUTICS, INC.","symbol":"HALO"},"owners":[{"id":29281,"kind":"person","name":"MATSUI CONNIE","position":1,"cik":"0001236537","reported_name":"MATSUI CONNIE","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-04-29T22:05:41.000Z","date":"2024-04-25","kind":"grant","planned":false,"acquired":true,"shares":6501,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents annual restricted stock unit (\"RSU\") grant under the Issuer's director compensation program.   Each RSU represents the right to receive one share of common stock of the Issuer.  This grant will vest in full on the earlier of (i) April 25, 2025 and (ii) the date of the Issuer's next annual meeting of stockholders."}],"balance_after":193505,"source":{"system":"sec-edgar","filing":"0001415889-24-011698","document":"form4-04292024_100436.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1159036/000141588924011698/form4-04292024_100436.xml","form_type":"4"}},{"id":1606657,"issuer":{"id":8413,"kind":"organization","name":"ARTELO BIOSCIENCES, INC."},"owners":[{"id":29281,"kind":"person","name":"MATSUI CONNIE","position":1,"cik":"0001236537","reported_name":"MATSUI CONNIE","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2024-03-01T23:09:12.000Z","date":"2024-02-28","kind":"grant","planned":false,"acquired":true,"shares":1083,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The Reporting Person agreed to certain amendments of their outstanding stock option pursuant to the terms of a repricing and revesting offer approved by the Issuer's Compensation Committee of the Board of Directors (the \"Offer\") relating to a one-time offer by the Issuer to reprice and adjust the vesting of certain Eligible Options (as defined in the Offer)."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F8","text":"Pursuant to the Offer, and subject to the Reporting Person continuing to be a Service Provider (as such term is defined in the Issuer's Plan) through each such applicable vesting date, one third (1/3rd) of the shares subject to the option shall vest on the first anniversary of the Amendment Date, and one thirty-sixth (1/36th) of the shares subject to the option shall vest each month thereafter on the same day of the month as the Amendment Date (or, if there is no such day, the last day of the month).  \"Amendment Date\" shall mean February 28, 2024."}],"balance_after":1083,"derivative":{"exercise_price":1.55,"expiration_date":"2033-08-04","underlying":"Common Stock","underlying_shares":1083},"source":{"system":"sec-edgar","filing":"0001640334-24-000329","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":12,"url":"https://www.sec.gov/Archives/edgar/data/1236537/000164033424000329/primary_doc.xml","form_type":"4"}},{"id":1606656,"issuer":{"id":8413,"kind":"organization","name":"ARTELO BIOSCIENCES, INC."},"owners":[{"id":29281,"kind":"person","name":"MATSUI CONNIE","position":1,"cik":"0001236537","reported_name":"MATSUI CONNIE","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2024-03-01T23:09:12.000Z","date":"2024-02-28","kind":"grant","planned":false,"acquired":true,"shares":667,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The Reporting Person agreed to certain amendments of their outstanding stock option pursuant to the terms of a repricing and revesting offer approved by the Issuer's Compensation Committee of the Board of Directors (the \"Offer\") relating to a one-time offer by the Issuer to reprice and adjust the vesting of certain Eligible Options (as defined in the Offer)."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F8","text":"Pursuant to the Offer, and subject to the Reporting Person continuing to be a Service Provider (as such term is defined in the Issuer's Plan) through each such applicable vesting date, one third (1/3rd) of the shares subject to the option shall vest on the first anniversary of the Amendment Date, and one thirty-sixth (1/36th) of the shares subject to the option shall vest each month thereafter on the same day of the month as the Amendment Date (or, if there is no such day, the last day of the month).  \"Amendment Date\" shall mean February 28, 2024."}],"balance_after":667,"derivative":{"exercise_price":1.55,"expiration_date":"2033-06-30","underlying":"Common Stock","underlying_shares":667},"source":{"system":"sec-edgar","filing":"0001640334-24-000329","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/1236537/000164033424000329/primary_doc.xml","form_type":"4"}},{"id":1606655,"issuer":{"id":8413,"kind":"organization","name":"ARTELO BIOSCIENCES, INC."},"owners":[{"id":29281,"kind":"person","name":"MATSUI CONNIE","position":1,"cik":"0001236537","reported_name":"MATSUI CONNIE","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2024-03-01T23:09:12.000Z","date":"2024-02-28","kind":"grant","planned":false,"acquired":true,"shares":667,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The Reporting Person agreed to certain amendments of their outstanding stock option pursuant to the terms of a repricing and revesting offer approved by the Issuer's Compensation Committee of the Board of Directors (the \"Offer\") relating to a one-time offer by the Issuer to reprice and adjust the vesting of certain Eligible Options (as defined in the Offer)."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F8","text":"Pursuant to the Offer, and subject to the Reporting Person continuing to be a Service Provider (as such term is defined in the Issuer's Plan) through each such applicable vesting date, one third (1/3rd) of the shares subject to the option shall vest on the first anniversary of the Amendment Date, and one thirty-sixth (1/36th) of the shares subject to the option shall vest each month thereafter on the same day of the month as the Amendment Date (or, if there is no such day, the last day of the month).  \"Amendment Date\" shall mean February 28, 2024."}],"balance_after":667,"derivative":{"exercise_price":1.55,"expiration_date":"2032-06-24","underlying":"Common Stock","underlying_shares":667},"source":{"system":"sec-edgar","filing":"0001640334-24-000329","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1236537/000164033424000329/primary_doc.xml","form_type":"4"}},{"id":1606654,"issuer":{"id":8413,"kind":"organization","name":"ARTELO BIOSCIENCES, INC."},"owners":[{"id":29281,"kind":"person","name":"MATSUI CONNIE","position":1,"cik":"0001236537","reported_name":"MATSUI CONNIE","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2024-03-01T23:09:12.000Z","date":"2024-02-28","kind":"grant","planned":false,"acquired":true,"shares":667,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The Reporting Person agreed to certain amendments of their outstanding stock option pursuant to the terms of a repricing and revesting offer approved by the Issuer's Compensation Committee of the Board of Directors (the \"Offer\") relating to a one-time offer by the Issuer to reprice and adjust the vesting of certain Eligible Options (as defined in the Offer)."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F8","text":"Pursuant to the Offer, and subject to the Reporting Person continuing to be a Service Provider (as such term is defined in the Issuer's Plan) through each such applicable vesting date, one third (1/3rd) of the shares subject to the option shall vest on the first anniversary of the Amendment Date, and one thirty-sixth (1/36th) of the shares subject to the option shall vest each month thereafter on the same day of the month as the Amendment Date (or, if there is no such day, the last day of the month).  \"Amendment Date\" shall mean February 28, 2024."}],"balance_after":667,"derivative":{"exercise_price":1.55,"expiration_date":"2031-07-16","underlying":"Common Stock","underlying_shares":667},"source":{"system":"sec-edgar","filing":"0001640334-24-000329","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1236537/000164033424000329/primary_doc.xml","form_type":"4"}},{"id":1606653,"issuer":{"id":8413,"kind":"organization","name":"ARTELO BIOSCIENCES, INC."},"owners":[{"id":29281,"kind":"person","name":"MATSUI CONNIE","position":1,"cik":"0001236537","reported_name":"MATSUI CONNIE","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2024-03-01T23:09:12.000Z","date":"2024-02-28","kind":"grant","planned":false,"acquired":true,"shares":10634,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The Reporting Person agreed to certain amendments of their outstanding stock option pursuant to the terms of a repricing and revesting offer approved by the Issuer's Compensation Committee of the Board of Directors (the \"Offer\") relating to a one-time offer by the Issuer to reprice and adjust the vesting of certain Eligible Options (as defined in the Offer)."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F8","text":"Pursuant to the Offer, and subject to the Reporting Person continuing to be a Service Provider (as such term is defined in the Issuer's Plan) through each such applicable vesting date, one third (1/3rd) of the shares subject to the option shall vest on the first anniversary of the Amendment Date, and one thirty-sixth (1/36th) of the shares subject to the option shall vest each month thereafter on the same day of the month as the Amendment Date (or, if there is no such day, the last day of the month).  \"Amendment Date\" shall mean February 28, 2024."}],"balance_after":10634,"derivative":{"exercise_price":1.55,"expiration_date":"2031-02-12","underlying":"Common Stock","underlying_shares":10634},"source":{"system":"sec-edgar","filing":"0001640334-24-000329","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1236537/000164033424000329/primary_doc.xml","form_type":"4"}},{"id":1606652,"issuer":{"id":8413,"kind":"organization","name":"ARTELO BIOSCIENCES, INC."},"owners":[{"id":29281,"kind":"person","name":"MATSUI CONNIE","position":1,"cik":"0001236537","reported_name":"MATSUI CONNIE","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2024-03-01T23:09:12.000Z","date":"2024-02-28","kind":"grant","planned":false,"acquired":true,"shares":1767,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The Reporting Person agreed to certain amendments of their outstanding stock option pursuant to the terms of a repricing and revesting offer approved by the Issuer's Compensation Committee of the Board of Directors (the \"Offer\") relating to a one-time offer by the Issuer to reprice and adjust the vesting of certain Eligible Options (as defined in the Offer)."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F8","text":"Pursuant to the Offer, and subject to the Reporting Person continuing to be a Service Provider (as such term is defined in the Issuer's Plan) through each such applicable vesting date, one third (1/3rd) of the shares subject to the option shall vest on the first anniversary of the Amendment Date, and one thirty-sixth (1/36th) of the shares subject to the option shall vest each month thereafter on the same day of the month as the Amendment Date (or, if there is no such day, the last day of the month).  \"Amendment Date\" shall mean February 28, 2024."}],"balance_after":1767,"derivative":{"exercise_price":1.55,"expiration_date":"2029-08-29","underlying":"Common Stock","underlying_shares":1767},"source":{"system":"sec-edgar","filing":"0001640334-24-000329","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1236537/000164033424000329/primary_doc.xml","form_type":"4"}},{"id":1606651,"issuer":{"id":8413,"kind":"organization","name":"ARTELO BIOSCIENCES, INC."},"owners":[{"id":29281,"kind":"person","name":"MATSUI CONNIE","position":1,"cik":"0001236537","reported_name":"MATSUI CONNIE","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2024-03-01T23:09:12.000Z","date":"2024-02-28","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":1083,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The Reporting Person agreed to certain amendments of their outstanding stock option pursuant to the terms of a repricing and revesting offer approved by the Issuer's Compensation Committee of the Board of Directors (the \"Offer\") relating to a one-time offer by the Issuer to reprice and adjust the vesting of certain Eligible Options (as defined in the Offer)."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"Subject to the Reporting Person continuing to be a Service Provider (as such term is defined in the Issuer's Plan) through each such applicable vesting date, one hundred percent (100%) of the shares subject to the option shall vest on the earlier of (i) the one (1) year anniversary of the Vesting Commencement Date, or (ii) the day prior to the date of the annual meeting of the Issuer's stockholders next following the Vesting Commencement Date. \"Vesting Commencement Date\" shall mean August 4, 2023."}],"balance_after":0,"derivative":{"exercise_price":2.01,"expiration_date":"2033-08-04","underlying":"Common Stock","underlying_shares":1083},"source":{"system":"sec-edgar","filing":"0001640334-24-000329","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1236537/000164033424000329/primary_doc.xml","form_type":"4"}},{"id":1606650,"issuer":{"id":8413,"kind":"organization","name":"ARTELO BIOSCIENCES, INC."},"owners":[{"id":29281,"kind":"person","name":"MATSUI CONNIE","position":1,"cik":"0001236537","reported_name":"MATSUI CONNIE","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2024-03-01T23:09:12.000Z","date":"2024-02-28","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":667,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The Reporting Person agreed to certain amendments of their outstanding stock option pursuant to the terms of a repricing and revesting offer approved by the Issuer's Compensation Committee of the Board of Directors (the \"Offer\") relating to a one-time offer by the Issuer to reprice and adjust the vesting of certain Eligible Options (as defined in the Offer)."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"Subject to the Reporting Person continuing to be a Service Provider (as such term is defined in the Issuer's 2018 Equity Incentive Plan (the \"Plan\")) through each such applicable vesting date, one hundred percent (100%) of the shares subject to the option shall vest on the earlier of (i) the one (1) year anniversary of the Vesting Commencement Date, or (ii) the day prior to the date of the annual meeting of the Issuer's stockholders next following the Vesting Commencement Date. \"Vesting Commencement Date\" shall mean June 30, 2023."}],"balance_after":0,"derivative":{"exercise_price":1.99,"expiration_date":"2033-06-30","underlying":"Common Stock","underlying_shares":667},"source":{"system":"sec-edgar","filing":"0001640334-24-000329","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1236537/000164033424000329/primary_doc.xml","form_type":"4"}},{"id":1606649,"issuer":{"id":8413,"kind":"organization","name":"ARTELO BIOSCIENCES, INC."},"owners":[{"id":29281,"kind":"person","name":"MATSUI CONNIE","position":1,"cik":"0001236537","reported_name":"MATSUI CONNIE","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2024-03-01T23:09:12.000Z","date":"2024-02-28","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":667,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F5","text":"This option was granted on June 24, 2022 and was previously reported as covering 10,000 shares at an exercise price of $0.326 per share, but was adjusted to reflect a 1-for-15 reverse stock split that occurred on August 10, 2022."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The Reporting Person agreed to certain amendments of their outstanding stock option pursuant to the terms of a repricing and revesting offer approved by the Issuer's Compensation Committee of the Board of Directors (the \"Offer\") relating to a one-time offer by the Issuer to reprice and adjust the vesting of certain Eligible Options (as defined in the Offer)."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F5","text":"This option was granted on June 24, 2022 and was previously reported as covering 10,000 shares at an exercise price of $0.326 per share, but was adjusted to reflect a 1-for-15 reverse stock split that occurred on August 10, 2022."}],"balance_after":0,"derivative":{"exercise_price":4.89,"exercise_date":"2023-06-24","expiration_date":"2032-06-24","underlying":"Common Stock","underlying_shares":667},"source":{"system":"sec-edgar","filing":"0001640334-24-000329","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1236537/000164033424000329/primary_doc.xml","form_type":"4"}},{"id":1606648,"issuer":{"id":8413,"kind":"organization","name":"ARTELO BIOSCIENCES, INC."},"owners":[{"id":29281,"kind":"person","name":"MATSUI CONNIE","position":1,"cik":"0001236537","reported_name":"MATSUI CONNIE","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2024-03-01T23:09:12.000Z","date":"2024-02-28","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":667,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"This option was granted on July 16, 2021 and was previously reported as covering 10,000 shares at an exercise price of $1.00 per share, but was adjusted to reflect a 1-for-15 reverse stock split that occurred on August 10, 2022."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The Reporting Person agreed to certain amendments of their outstanding stock option pursuant to the terms of a repricing and revesting offer approved by the Issuer's Compensation Committee of the Board of Directors (the \"Offer\") relating to a one-time offer by the Issuer to reprice and adjust the vesting of certain Eligible Options (as defined in the Offer)."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F4","text":"This option was granted on July 16, 2021 and was previously reported as covering 10,000 shares at an exercise price of $1.00 per share, but was adjusted to reflect a 1-for-15 reverse stock split that occurred on August 10, 2022."}],"balance_after":0,"derivative":{"exercise_price":15,"exercise_date":"2022-06-23","expiration_date":"2031-07-16","underlying":"Common Stock","underlying_shares":667},"source":{"system":"sec-edgar","filing":"0001640334-24-000329","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1236537/000164033424000329/primary_doc.xml","form_type":"4"}},{"id":1606647,"issuer":{"id":8413,"kind":"organization","name":"ARTELO BIOSCIENCES, INC."},"owners":[{"id":29281,"kind":"person","name":"MATSUI CONNIE","position":1,"cik":"0001236537","reported_name":"MATSUI CONNIE","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2024-03-01T23:09:12.000Z","date":"2024-02-28","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":10634,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"This option was granted on February 12, 2021 and was previously reported as covering 159,500 shares at an exercise price of $2.66 per share, but was adjusted to reflect a 1-for-15 reverse stock split that occurred on August 10, 2022."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The Reporting Person agreed to certain amendments of their outstanding stock option pursuant to the terms of a repricing and revesting offer approved by the Issuer's Compensation Committee of the Board of Directors (the \"Offer\") relating to a one-time offer by the Issuer to reprice and adjust the vesting of certain Eligible Options (as defined in the Offer)."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F3","text":"This option was granted on February 12, 2021 and was previously reported as covering 159,500 shares at an exercise price of $2.66 per share, but was adjusted to reflect a 1-for-15 reverse stock split that occurred on August 10, 2022."}],"balance_after":0,"derivative":{"exercise_price":39.9,"exercise_date":"2023-02-12","expiration_date":"2031-02-12","underlying":"Common Stock","underlying_shares":10634},"source":{"system":"sec-edgar","filing":"0001640334-24-000329","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1236537/000164033424000329/primary_doc.xml","form_type":"4"}},{"id":1606646,"issuer":{"id":8413,"kind":"organization","name":"ARTELO BIOSCIENCES, INC."},"owners":[{"id":29281,"kind":"person","name":"MATSUI CONNIE","position":1,"cik":"0001236537","reported_name":"MATSUI CONNIE","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2024-03-01T23:09:12.000Z","date":"2024-02-28","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":1767,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"This option was granted on August 29, 2019 and was previously reported as covering 26,500 shares at an exercise price of $1.99 per share, but was adjusted to reflect a 1-for-15 reverse stock split that occurred on August 10, 2022."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The Reporting Person agreed to certain amendments of their outstanding stock option pursuant to the terms of a repricing and revesting offer approved by the Issuer's Compensation Committee of the Board of Directors (the \"Offer\") relating to a one-time offer by the Issuer to reprice and adjust the vesting of certain Eligible Options (as defined in the Offer)."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F1","text":"This option was granted on August 29, 2019 and was previously reported as covering 26,500 shares at an exercise price of $1.99 per share, but was adjusted to reflect a 1-for-15 reverse stock split that occurred on August 10, 2022."}],"balance_after":0,"derivative":{"exercise_price":29.85,"exercise_date":"2020-02-29","expiration_date":"2029-08-29","underlying":"Common Stock","underlying_shares":1767},"source":{"system":"sec-edgar","filing":"0001640334-24-000329","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1236537/000164033424000329/primary_doc.xml","form_type":"4"}},{"id":1812817,"issuer":{"id":8413,"kind":"organization","name":"ARTELO BIOSCIENCES, INC."},"owners":[{"id":29281,"kind":"person","name":"MATSUI CONNIE","position":1,"cik":"0001236537","reported_name":"MATSUI CONNIE","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2023-08-08T20:58:37.000Z","date":"2023-08-04","kind":"grant","planned":false,"acquired":true,"shares":1083,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Subject to the Reporting Person continuing to be a Service Provider (as such term is defined in the Issuer's 2018 Equity Incentive Plan) through each such applicable vesting date, one hundred percent (100%) of the shares subject to the option shall vest on the earlier of (i) the one (1) year anniversary of the Vesting Commencement Date, or (ii) the day prior to the date of the annual meeting of the Issuer's stockholders next following the Vesting Commencement Date. \"Vesting Commencement Date\" shall mean August 4, 2023."}],"balance_after":1083,"derivative":{"exercise_price":2.01,"expiration_date":"2033-08-04","underlying":"Common Stock","underlying_shares":1083},"source":{"system":"sec-edgar","filing":"0001640334-23-001492","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1236537/000164033423001492/form4.xml","form_type":"4"}},{"id":1839480,"issuer":{"id":8413,"kind":"organization","name":"ARTELO BIOSCIENCES, INC."},"owners":[{"id":29281,"kind":"person","name":"MATSUI CONNIE","position":1,"cik":"0001236537","reported_name":"MATSUI CONNIE","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2023-07-03T18:05:13.000Z","date":"2023-06-30","kind":"grant","planned":false,"acquired":true,"shares":667,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Subject to the Reporting Person continuing to be a Service Provider (as such term is defined in the Issuer's 2018 Equity Incentive Plan) through each such applicable vesting date, one hundred percent (100%) of the shares subject to the option shall vest on the earlier of (i) the one (1) year anniversary of the Vesting Commencement Date, or (ii) the day prior to the date of the annual meeting of the Issuer's stockholders next following the Vesting Commencement Date. \"Vesting Commencement Date\" shall mean June 30, 2023."}],"balance_after":667,"derivative":{"exercise_price":2.01,"expiration_date":"2033-06-30","underlying":"Common Stock","underlying_shares":667},"source":{"system":"sec-edgar","filing":"0001640334-23-001200","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1236537/000164033423001200/form4.xml","form_type":"4"}},{"id":1858545,"issuer":{"id":5797,"kind":"organization","name":"SUTRO BIOPHARMA, INC.","symbol":"STRO"},"owners":[{"id":29281,"kind":"person","name":"MATSUI CONNIE","position":1,"cik":"0001236537","reported_name":"MATSUI CONNIE","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2023-06-12T22:38:13.000Z","date":"2023-06-08","kind":"grant","planned":false,"acquired":true,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests as to 8.33% of the total shares monthly, commencing July 8, 2023, with 100% of the total shares vested and exercisable on the earlier of the issuer's 2024 annual stockholders meeting or June 8, 2024, subject to the reporting person's provision of service to the issuer on each vesting date."}],"balance_after":25000,"derivative":{"exercise_price":5.12,"expiration_date":"2033-06-08","underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001209191-23-036471","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1236537/000120919123036471/doc4.xml","form_type":"4"}},{"id":1899768,"issuer":{"id":793,"kind":"organization","name":"HALOZYME THERAPEUTICS, INC.","symbol":"HALO"},"owners":[{"id":29281,"kind":"person","name":"MATSUI CONNIE","position":1,"cik":"0001236537","reported_name":"MATSUI CONNIE","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option to Purchase Common Stock","published_at":"2023-05-09T22:21:33.000Z","date":"2023-05-05","kind":"grant","planned":false,"acquired":true,"shares":11371,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Represents annual stock option grant under the Issuer's director compensation program.  This grant will vest in full on the earlier of (i) May 5, 2024 and (ii) the date of the Issuer's next annual meeting of stockholders."}],"balance_after":11371,"derivative":{"exercise_price":31,"exercise_date":"2024-05-05","expiration_date":"2033-05-05","underlying":"Common Stock","underlying_shares":11371},"source":{"system":"sec-edgar","filing":"0001415889-23-007692","document":"form4-05092023_100523.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1159036/000141588923007692/form4-05092023_100523.xml","form_type":"4"}},{"id":1899767,"issuer":{"id":793,"kind":"organization","name":"HALOZYME THERAPEUTICS, INC.","symbol":"HALO"},"owners":[{"id":29281,"kind":"person","name":"MATSUI CONNIE","position":1,"cik":"0001236537","reported_name":"MATSUI CONNIE","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-05-09T22:21:33.000Z","date":"2023-05-05","kind":"grant","planned":false,"acquired":true,"shares":8065,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents annual restricted stock unit (\"RSU\") grant under the Issuer's director compensation program.   Each RSU represents the right to receive one share of common stock of the Issuer.  This grant will vest in full on the earlier of (i) May 5, 2024 and (ii) the date of the Issuer's next annual meeting of stockholders."}],"balance_after":187004,"source":{"system":"sec-edgar","filing":"0001415889-23-007692","document":"form4-05092023_100523.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1159036/000141588923007692/form4-05092023_100523.xml","form_type":"4"}},{"id":2112716,"issuer":{"id":793,"kind":"organization","name":"HALOZYME THERAPEUTICS, INC.","symbol":"HALO"},"owners":[{"id":29281,"kind":"person","name":"MATSUI CONNIE","position":1,"cik":"0001236537","reported_name":"MATSUI CONNIE","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-11-17T22:11:53.000Z","date":"2022-11-16","kind":"gift","acquired":false,"shares":9250,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents a bona fide gift to charity."}],"balance_after":178939,"source":{"system":"sec-edgar","filing":"0001415889-22-011512","document":"form4-11172022_101138.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1159036/000141588922011512/form4-11172022_101138.xml","form_type":"4"}},{"id":2221020,"issuer":{"id":8413,"kind":"organization","name":"ARTELO BIOSCIENCES, INC."},"owners":[{"id":29281,"kind":"person","name":"MATSUI CONNIE","position":1,"cik":"0001236537","reported_name":"MATSUI CONNIE","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2022-06-27T21:20:28.000Z","date":"2022-06-24","kind":"grant","acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Subject to the Reporting Person continuing to be a Service Provider (as such term is defined in the Issuer's 2018 Equity Incentive Plan) through each such applicable vesting date, one hundred percent (100%) of the shares subject to the option shall vest on the earlier of (i) the one (1) year anniversary of the Vesting Commencement Date, or (ii) the day prior to the date of the annual meeting of the Issuer's stockholders next following the Vesting Commencement Date. \"Vesting Commencement Date\" shall mean June 24, 2022."}],"balance_after":10000,"derivative":{"exercise_price":0.326,"expiration_date":"2032-06-24","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001640334-22-001363","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1236537/000164033422001363/form4.xml","form_type":"4"}},{"id":2238891,"issuer":{"id":5797,"kind":"organization","name":"SUTRO BIOPHARMA, INC.","symbol":"STRO"},"owners":[{"id":29281,"kind":"person","name":"MATSUI CONNIE","position":1,"cik":"0001236537","reported_name":"MATSUI CONNIE","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2022-06-08T23:07:02.000Z","date":"2022-06-06","kind":"grant","acquired":true,"shares":18500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests as to 8.33% of the total shares monthly, commencing July 6, 2022, with 100% of the total shares vested and exercisable on the earlier of the issuer's 2023 annual stockholders meeting or June 6, 2023,  subject to the reporting person's provision of service to the issuer on each vesting date."}],"balance_after":18500,"derivative":{"exercise_price":4.44,"expiration_date":"2032-06-05","underlying":"Common Stock","underlying_shares":18500},"source":{"system":"sec-edgar","filing":"0001209191-22-035209","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1236537/000120919122035209/doc4.xml","form_type":"4"}},{"id":2279551,"issuer":{"id":793,"kind":"organization","name":"HALOZYME THERAPEUTICS, INC.","symbol":"HALO"},"owners":[{"id":29281,"kind":"person","name":"MATSUI CONNIE","position":1,"cik":"0001236537","reported_name":"MATSUI CONNIE","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2022-05-07T00:06:48.000Z","date":"2022-05-05","kind":"grant","acquired":true,"shares":6206,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents annual restricted stock unit grant under the Issuer's director compensation program. This grant will vest in full on the earlier of (i) May 5, 2023 and (ii) the date of the Issuer's next annual meeting of stockholders."}],"balance_after":188189,"source":{"system":"sec-edgar","filing":"0001179110-22-002910","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1159036/000117911022002910/edgar.xml","form_type":"4"}},{"id":2523265,"issuer":{"id":793,"kind":"organization","name":"HALOZYME THERAPEUTICS, INC.","symbol":"HALO"},"owners":[{"id":29281,"kind":"person","name":"MATSUI CONNIE","position":1,"cik":"0001236537","reported_name":"MATSUI CONNIE","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-11-05T21:59:41.000Z","date":"2021-11-05","kind":"sale","acquired":false,"shares":12548,"price":40.77,"value":511581.96,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents a weighted average sales price per share. These shares were sold at prices ranging from $40.622 to $41.04. The Reporting Person has provided to the issuer, and will provide to any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range."}],"balance_after":181983,"source":{"system":"sec-edgar","filing":"0001179110-21-009910","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1159036/000117911021009910/edgar.xml","form_type":"4"}},{"id":2523264,"issuer":{"id":793,"kind":"organization","name":"HALOZYME THERAPEUTICS, INC.","symbol":"HALO"},"owners":[{"id":29281,"kind":"person","name":"MATSUI CONNIE","position":1,"cik":"0001236537","reported_name":"MATSUI CONNIE","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-11-05T21:59:41.000Z","date":"2021-11-05","kind":"sale","acquired":false,"shares":19452,"price":40.126,"value":780530.952,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents a weighted average sales price per share. These shares were sold at prices ranging from $39.59 to $40.57. The Reporting Person has provided to the issuer, and will provide to any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range."}],"balance_after":194531,"source":{"system":"sec-edgar","filing":"0001179110-21-009910","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1159036/000117911021009910/edgar.xml","form_type":"4"}},{"id":2624786,"issuer":{"id":8413,"kind":"organization","name":"ARTELO BIOSCIENCES, INC."},"owners":[{"id":29281,"kind":"person","name":"MATSUI CONNIE","position":1,"cik":"0001236537","reported_name":"MATSUI CONNIE","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2021-07-26T20:33:42.000Z","date":"2021-07-16","kind":"grant","acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Subject to the Reporting Person continuing to be a Service Provider (as such term is defined in the Issuer's 2018 Equity Incentive Plan) through each such applicable vesting date, one hundred percent (100%) of the shares subject to the option shall vest on the earlier of (i) the one (1) year anniversary of the Vesting Commencement Date, or (ii) the day prior to the date of the annual meeting of the Issuer's stockholders next following the Vesting Commencement Date. \"Vesting Commencement Date\" shall mean July 16, 2021."}],"balance_after":10000,"derivative":{"exercise_price":1,"expiration_date":"2031-07-16","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001640334-21-001686","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1236537/000164033421001686/form4.xml","form_type":"4"}},{"id":2679046,"issuer":{"id":5797,"kind":"organization","name":"SUTRO BIOPHARMA, INC.","symbol":"STRO"},"owners":[{"id":29281,"kind":"person","name":"MATSUI CONNIE","position":1,"cik":"0001236537","reported_name":"MATSUI CONNIE","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2021-06-07T21:04:56.000Z","date":"2021-06-03","kind":"grant","acquired":true,"shares":18500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests as to 8.33% of the total shares monthly, commencing July 3, 2021, with 100% of the total shares vested and exercisable on the earlier of the issuer's 2022 annual stockholders meeting or June 3, 2022,  subject to the reporting person's provision of service to the issuer on each vesting date."}],"balance_after":18500,"derivative":{"exercise_price":18.21,"expiration_date":"2031-06-02","underlying":"Common Stock","underlying_shares":18500},"source":{"system":"sec-edgar","filing":"0001209191-21-038685","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1236537/000120919121038685/doc4.xml","form_type":"4"}},{"id":2725297,"issuer":{"id":793,"kind":"organization","name":"HALOZYME THERAPEUTICS, INC.","symbol":"HALO"},"owners":[{"id":29281,"kind":"person","name":"MATSUI CONNIE","position":1,"cik":"0001236537","reported_name":"MATSUI CONNIE","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2021-05-07T00:03:30.000Z","date":"2021-05-05","kind":"grant","acquired":true,"shares":5230,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents annual restricted stock unit grant under the Issuer's director compensation program. This grant will vest in full on the earlier of (i) May 5, 2022 and (ii) the date of the Issuer's next annual meeting of stockholders."}],"balance_after":213983,"source":{"system":"sec-edgar","filing":"0001179110-21-004973","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1159036/000117911021004973/edgar.xml","form_type":"4"}},{"id":2853956,"issuer":{"id":8413,"kind":"organization","name":"ARTELO BIOSCIENCES, INC."},"owners":[{"id":29281,"kind":"person","name":"MATSUI CONNIE","position":1,"cik":"0001236537","reported_name":"MATSUI CONNIE","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2021-02-17T22:14:02.000Z","date":"2021-02-12","kind":"grant","acquired":true,"shares":159500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Subject to the Reporting Person continuing to be a Service Provider (as such term is defined in the Issuer's 2018 Equity Incentive Plan) through each such applicable vesting date, fifty percent (50%) of the shares subject to the option shall vest on the one (1) year anniversary of the Vesting Commencement Date, and fifty percent (50%) of the shares subject to the option shall vest on the two (2) year anniversary of the Vesting Commencement Date, such that the option shall be fully vested on the two (2) year anniversary of the Vesting Commencement Date. \"Vesting Commencement Date\" shall mean February 12, 2021."}],"balance_after":159500,"derivative":{"exercise_price":2.66,"expiration_date":"2031-02-12","underlying":"Common Stock","underlying_shares":159500},"source":{"system":"sec-edgar","filing":"0001640334-21-000385","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1236537/000164033421000385/form4.xml","form_type":"4"}},{"id":3032473,"issuer":{"id":793,"kind":"organization","name":"HALOZYME THERAPEUTICS, INC.","symbol":"HALO"},"owners":[{"id":29281,"kind":"person","name":"MATSUI CONNIE","position":1,"cik":"0001236537","reported_name":"MATSUI CONNIE","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-09-14T21:33:33.000Z","date":"2020-09-14","kind":"gift","acquired":false,"shares":8000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Represents a bona fide gift to a charitable organization."}],"balance_after":208753,"source":{"system":"sec-edgar","filing":"0001179110-20-009727","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1159036/000117911020009727/edgar.xml","form_type":"4"}},{"id":3032472,"issuer":{"id":793,"kind":"organization","name":"HALOZYME THERAPEUTICS, INC.","symbol":"HALO"},"owners":[{"id":29281,"kind":"person","name":"MATSUI CONNIE","position":1,"cik":"0001236537","reported_name":"MATSUI CONNIE","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-09-14T21:33:33.000Z","date":"2020-09-11","kind":"sale","acquired":false,"shares":32000,"price":27.056,"value":865792.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents a weighted average sales price per share. These shares were sold at prices ranging from $26.95 to $27.16. The Reporting Person has provided to the issuer, and will provide to any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range."}],"balance_after":216753,"source":{"system":"sec-edgar","filing":"0001179110-20-009727","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1159036/000117911020009727/edgar.xml","form_type":"4"}},{"id":3118384,"issuer":{"id":5797,"kind":"organization","name":"SUTRO BIOPHARMA, INC.","symbol":"STRO"},"owners":[{"id":29281,"kind":"person","name":"MATSUI CONNIE","position":1,"cik":"0001236537","reported_name":"MATSUI CONNIE","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2020-06-08T21:28:01.000Z","date":"2020-06-05","kind":"grant","acquired":true,"shares":12000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option is fully vested on June 5, 2021, subject to the reporting person's provision of service to the issuer on the vesting date."}],"balance_after":12000,"derivative":{"exercise_price":9.83,"expiration_date":"2030-06-04","underlying":"Common Stock","underlying_shares":12000},"source":{"system":"sec-edgar","filing":"0001209191-20-035030","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1236537/000120919120035030/doc4.xml","form_type":"4"}},{"id":3165562,"issuer":{"id":793,"kind":"organization","name":"HALOZYME THERAPEUTICS, INC.","symbol":"HALO"},"owners":[{"id":29281,"kind":"person","name":"MATSUI CONNIE","position":1,"cik":"0001236537","reported_name":"MATSUI CONNIE","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-05-01T23:14:08.000Z","date":"2020-04-30","kind":"grant","acquired":true,"shares":8829,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents annual restricted stock grant under the Issuer's director compensation program. This grant will vest in full on the earlier of (i) April 30, 2021 or (ii) the date of the Issuer's next annual meeting of stockholders."}],"balance_after":248753,"source":{"system":"sec-edgar","filing":"0001179110-20-005380","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1159036/000117911020005380/edgar.xml","form_type":"4"}},{"id":3477948,"issuer":{"id":5797,"kind":"organization","name":"SUTRO BIOPHARMA, INC.","symbol":"STRO"},"owners":[{"id":29281,"kind":"person","name":"MATSUI CONNIE","position":1,"cik":"0001236537","reported_name":"MATSUI CONNIE","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy Common Stock)","published_at":"2019-06-26T20:52:34.000Z","date":"2019-06-24","kind":"grant","acquired":true,"shares":23076,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests as to 1/36th of the total shares monthly, beginning on July 24, 2019, with 100% of the total shares vested and exercisable on June 24, 2022, subject to the reporting person's provision of service to the issuer on each vesting date."}],"balance_after":23076,"derivative":{"exercise_price":11.68,"expiration_date":"2029-06-24","underlying":"Common Stock","underlying_shares":23076},"source":{"system":"sec-edgar","filing":"0001209191-19-039123","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1236537/000120919119039123/doc4.xml","form_type":"4"}},{"id":3540218,"issuer":{"id":793,"kind":"organization","name":"HALOZYME THERAPEUTICS, INC.","symbol":"HALO"},"owners":[{"id":29281,"kind":"person","name":"MATSUI CONNIE","position":1,"cik":"0001236537","reported_name":"MATSUI CONNIE","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-05-03T20:20:33.000Z","date":"2019-05-02","kind":"grant","acquired":true,"shares":12173,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents annual restricted stock grant under the Issuer's director compensation program. This grant will vest in full on the earlier of (i) May 2, 2020 or (ii) the date of the Issuer's next annual meeting of stockholders."}],"balance_after":239924,"source":{"system":"sec-edgar","filing":"0001179110-19-005508","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1159036/000117911019005508/edgar.xml","form_type":"4"}},{"id":3737891,"issuer":{"id":793,"kind":"organization","name":"HALOZYME THERAPEUTICS, INC.","symbol":"HALO"},"owners":[{"id":29281,"kind":"person","name":"MATSUI CONNIE","position":1,"cik":"0001236537","reported_name":"MATSUI CONNIE","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-12-10T21:19:23.000Z","date":"2018-12-07","kind":"gift","acquired":false,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents a bona fide gift to a charitable organization."}],"balance_after":227751,"source":{"system":"sec-edgar","filing":"0001179110-18-013625","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1159036/000117911018013625/edgar.xml","form_type":"4"}},{"id":3949891,"issuer":{"id":793,"kind":"organization","name":"HALOZYME THERAPEUTICS, INC.","symbol":"HALO"},"owners":[{"id":29281,"kind":"person","name":"MATSUI CONNIE","position":1,"cik":"0001236537","reported_name":"MATSUI CONNIE","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-05-02T23:42:03.000Z","date":"2018-05-02","kind":"grant","acquired":true,"shares":10363,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents annual restricted stock grant under the Issuer's director compensation program. This grant will vest in full on the earlier of (i) May 2, 2019 or (ii) the date of the Issuer's next annual meeting of stockholders."}],"balance_after":242751,"source":{"system":"sec-edgar","filing":"0001179110-18-006090","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1159036/000117911018006090/edgar.xml","form_type":"4"}},{"id":4204138,"issuer":{"id":793,"kind":"organization","name":"HALOZYME THERAPEUTICS, INC.","symbol":"HALO"},"owners":[{"id":29281,"kind":"person","name":"MATSUI CONNIE","position":1,"cik":"0001236537","reported_name":"MATSUI CONNIE","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-09-21T23:20:09.000Z","date":"2017-09-21","kind":"gift","acquired":false,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents a bona fide gift to a charitable organization."}],"balance_after":232388,"source":{"system":"sec-edgar","filing":"0001179110-17-012575","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1159036/000117911017012575/edgar.xml","form_type":"4"}},{"id":4328478,"issuer":{"id":793,"kind":"organization","name":"HALOZYME THERAPEUTICS, INC.","symbol":"HALO"},"owners":[{"id":29281,"kind":"person","name":"MATSUI CONNIE","position":1,"cik":"0001236537","reported_name":"MATSUI CONNIE","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Options to Purchase Common Stock","published_at":"2017-05-09T22:00:11.000Z","date":"2017-05-08","kind":"exercise","acquired":false,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"These options became fully vested and exercisable on the date immediately preceding the date of the annual stockholders' meeting following the date of grant."}],"balance_after":0,"derivative":{"exercise_price":10.37,"expiration_date":"2017-05-15","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001179110-17-006946","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1159036/000117911017006946/edgar.xml","form_type":"4"}},{"id":4328477,"issuer":{"id":793,"kind":"organization","name":"HALOZYME THERAPEUTICS, INC.","symbol":"HALO"},"owners":[{"id":29281,"kind":"person","name":"MATSUI CONNIE","position":1,"cik":"0001236537","reported_name":"MATSUI CONNIE","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-05-09T22:00:11.000Z","date":"2017-05-08","kind":"exercise","acquired":true,"shares":10000,"price":10.37,"value":103700.0,"ownership":{"direct":true},"balance_after":247388,"source":{"system":"sec-edgar","filing":"0001179110-17-006946","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1159036/000117911017006946/edgar.xml","form_type":"4"}},{"id":4331843,"issuer":{"id":793,"kind":"organization","name":"HALOZYME THERAPEUTICS, INC.","symbol":"HALO"},"owners":[{"id":29281,"kind":"person","name":"MATSUI CONNIE","position":1,"cik":"0001236537","reported_name":"MATSUI CONNIE","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-05-05T20:58:23.000Z","date":"2017-05-04","kind":"grant","acquired":true,"shares":14135,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents annual restricted stock grant under the Issuer's director compensation program. This grant will vest in full on the earlier of (i) May 4, 2018 or (ii) the date of the Issuer's next annual meeting of stockholders."}],"balance_after":237388,"source":{"system":"sec-edgar","filing":"0001179110-17-006701","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1159036/000117911017006701/edgar.xml","form_type":"4"}}]}